18 research outputs found
Yet another breakdown point notion: EFSBP - illustrated at scale-shape models
The breakdown point in its different variants is one of the central notions
to quantify the global robustness of a procedure. We propose a simple
supplementary variant which is useful in situations where we have no obvious or
only partial equivariance: Extending the Donoho and Huber(1983) Finite Sample
Breakdown Point, we propose the Expected Finite Sample Breakdown Point to
produce less configuration-dependent values while still preserving the finite
sample aspect of the former definition. We apply this notion for joint
estimation of scale and shape (with only scale-equivariance available),
exemplified for generalized Pareto, generalized extreme value, Weibull, and
Gamma distributions. In these settings, we are interested in highly-robust,
easy-to-compute initial estimators; to this end we study Pickands-type and
Location-Dispersion-type estimators and compute their respective breakdown
points.Comment: 21 pages, 4 figure
Infinitesimally Robust Estimation in General Smoothly Parametrized Models
We describe the shrinking neighborhood approach of Robust Statistics, which
applies to general smoothly parametrized models, especially, exponential
families. Equal generality is achieved by object oriented implementation of the
optimally robust estimators. We evaluate the estimates on real datasets from
literature by means of our R packages ROptEst and RobLox
YopJ-Induced Caspase-1 Activation in Yersinia-Infected Macrophages: Independent of Apoptosis, Linked to Necrosis, Dispensable for Innate Host Defense
Yersinia outer protein J (YopJ) is a type III secretion system (T3SS) effector of pathogenic Yersinia (Yersinia pestis, Yersinia enterocolitica and Yersinia pseudotuberculosis) that is secreted into host cells. YopJ inhibits survival response pathways in macrophages, causing cell death. Allelic variation of YopJ is responsible for differential cytotoxicity in Yersinia strains. YopJ isoforms in Y. enterocolitica O:8 (YopP) and Y. pestis KIM (YopJKIM) strains have high cytotoxic activity. In addition, YopJKIM-induced macrophage death is associated with caspase-1 activation and interleukin-1ÎČ (IL-1ÎČ secretion. Here, the mechanism of YopJKIM-induced cell death, caspase-1 activation, and IL-1ÎČ secretion in primary murine macrophages was examined. Caspase-3/7 activity was low and the caspase-3 substrate poly (ADP-ribose) polymerase (PARP) was not cleaved in Y. pestis KIM5-infected macrophages. In addition, cytotoxicity and IL-1ÎČ secretion were not reduced in the presence of a caspase-8 inhibitor, or in B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax)/Bcl-2 homologous antagonist/killer (Bak) knockout macrophages, showing that YopJKIM-mediated cell death and caspase-1 activation occur independent of mitochondrial-directed apoptosis. KIM5-infected macrophages released high mobility group protein B1 (HMGB1), a marker of necrosis, and microscopic analysis revealed that necrotic cells contained active caspase-1, indicating that caspase-1 activation is associated with necrosis. Inhibitor studies showed that receptor interacting protein 1 (RIP1) kinase and reactive oxygen species (ROS) were not required for cytotoxicity or IL-ÎČ release in KIM5-infected macrophages. IL-1ÎČ secretion was reduced in the presence of cathepsin B inhibitors, suggesting that activation of caspase-1 requires cathepsin B activity. Ectopically-expressed YopP caused higher cytotoxicity and secretion of IL-1ÎČ in Y. pseudotuberculosis-infected macrophages than YopJKIM. Wild-type and congenic caspase 1 knockout C57BL/6 mice were equally susceptible to lethal infection with Y. pseudotuberculosis ectopically expressing YopP. These data suggest that YopJ-induced caspase-1 activation in Yersinia-infected macrophages is a downstream consequence of necrotic cell death and is dispensable for innate host resistance to a strain with enhanced cytotoxicity
A Yersinia Effector with Enhanced Inhibitory Activity on the NF-ÎșB Pathway Activates the NLRP3/ASC/Caspase-1 Inflammasome in Macrophages
A type III secretion system (T3SS) in pathogenic Yersinia
species functions to translocate Yop effectors, which modulate cytokine
production and regulate cell death in macrophages. Distinct pathways of
T3SS-dependent cell death and caspase-1 activation occur in
Yersinia-infected macrophages. One pathway of cell death
and caspase-1 activation in macrophages requires the effector YopJ. YopJ is an
acetyltransferase that inactivates MAPK kinases and IKKÎČ to cause
TLR4-dependent apoptosis in naĂŻve macrophages. A YopJ isoform in Y.
pestis KIM (YopJKIM) has two amino acid substitutions,
F177L and K206E, not present in YopJ proteins of Y.
pseudotuberculosis and Y. pestis CO92. As compared
to other YopJ isoforms, YopJKIM causes increased apoptosis, caspase-1
activation, and secretion of IL-1ÎČ in Yersinia-infected
macrophages. The molecular basis for increased apoptosis and activation of
caspase-1 by YopJKIM in Yersinia-infected
macrophages was studied. Site directed mutagenesis showed that the F177L and
K206E substitutions in YopJKIM were important for enhanced apoptosis,
caspase-1 activation, and IL-1ÎČ secretion. As compared to
YopJCO92, YopJKIM displayed an enhanced capacity to
inhibit phosphorylation of IÎșB-α in macrophages and to bind IKKÎČ in
vitro. YopJKIM also showed a moderately increased ability to inhibit
phosphorylation of MAPKs. Increased caspase-1 cleavage and IL-1ÎČ secretion
occurred in IKKÎČ-deficient macrophages infected with Y.
pestis expressing YopJCO92, confirming that the
NF-ÎșB pathway can negatively regulate inflammasome activation.
K+ efflux, NLRP3 and ASC were important for secretion of
IL-1ÎČ in response to Y. pestis KIM infection as shown using
macrophages lacking inflammasome components or by the addition of exogenous KCl.
These data show that caspase-1 is activated in naĂŻve macrophages in
response to infection with a pathogen that inhibits IKKÎČ and MAPK kinases
and induces TLR4-dependent apoptosis. This pro-inflammatory form of apoptosis
may represent an early innate immune response to highly virulent pathogens such
as Y. pestis KIM that have evolved an enhanced ability to
inhibit host signaling pathways
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.
Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives. Since the field continues to expand and novel mechanisms that orchestrate multiple cell death pathways are unveiled, we propose an updated classification of cell death subroutines focusing on mechanistic and essential (as opposed to correlative and dispensable) aspects of the process. As we provide molecularly oriented definitions of terms including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe, we discuss the utility of neologisms that refer to highly specialized instances of these processes. The mission of the NCCD is to provide a widely accepted nomenclature on cell death in support of the continued development of the field
Preprocessing of gene expression data by optimally robust estimators
<p>Abstract</p> <p>Background</p> <p>The preprocessing of gene expression data obtained from several platforms routinely includes the aggregation of multiple raw signal intensities to one expression value. Examples are the computation of a single expression measure based on the perfect match (PM) and mismatch (MM) probes for the Affymetrix technology, the summarization of bead level values to bead summary values for the Illumina technology or the aggregation of replicated measurements in the case of other technologies including real-time quantitative polymerase chain reaction (RT-qPCR) platforms. The summarization of technical replicates is also performed in other "-omics" disciplines like proteomics or metabolomics.</p> <p>Preprocessing methods like MAS 5.0, Illumina's default summarization method, RMA, or VSN show that the use of robust estimators is widely accepted in gene expression analysis. However, the selection of robust methods seems to be mainly driven by their high breakdown point and not by efficiency.</p> <p>Results</p> <p>We describe how optimally robust radius-minimax (rmx) estimators, i.e. estimators that minimize an asymptotic maximum risk on shrinking neighborhoods about an ideal model, can be used for the aggregation of multiple raw signal intensities to one expression value for Affymetrix and Illumina data. With regard to the Affymetrix data, we have implemented an algorithm which is a variant of MAS 5.0.</p> <p>Using datasets from the literature and Monte-Carlo simulations we provide some reasoning for assuming approximate log-normal distributions of the raw signal intensities by means of the Kolmogorov distance, at least for the discussed datasets, and compare the results of our preprocessing algorithms with the results of Affymetrix's MAS 5.0 and Illumina's default method.</p> <p>The numerical results indicate that when using rmx estimators an accuracy improvement of about 10-20% is obtained compared to Affymetrix's MAS 5.0 and about 1-5% compared to Illumina's default method. The improvement is also visible in the analysis of technical replicates where the reproducibility of the values (in terms of Pearson and Spearman correlation) is increased for all Affymetrix and almost all Illumina examples considered. Our algorithms are implemented in the R package named <monospace>RobLoxBioC</monospace> which is publicly available via CRAN, The Comprehensive R Archive Network (<url>http://cran.r-project.org/web/packages/RobLoxBioC</url>/).</p> <p>Conclusions</p> <p>Optimally robust rmx estimators have a high breakdown point and are computationally feasible. They can lead to a considerable gain in efficiency for well-established bioinformatics procedures and thus, can increase the reproducibility and power of subsequent statistical analysis.</p
Older Patients' Aversion to Antidepressants: A Qualitative Study
BACKGROUND: Depression is common among older patients yet is often inadequately treated. Patient beliefs about antidepressants are known to affect treatment initiation and adherence, but are often not expressed in clinical settings. OBJECTIVE: To explore attitudes toward antidepressants in a sample of depressed, community-dwelling elders who were offered treatment. DESIGN: Cross-sectional, qualitative study utilizing semi-structured interviews. PARTICIPANTS: Primary care patients age 60 years and over with depression, from academic and community primary care practices of the University of Pennsylvania Health System and the Philadelphia Department of Veterans Affairs. Patients participated in either the Prevention of Suicide in Primary Care Elderly: Collaborative Trial or the Primary Care Research in Substance Abuse and Mental Health for the Elderly Trial. Sixty-eight patients were interviewed and responses from 42 participants with negative attitudes toward medication for depression were analyzed. MEASUREMENTS: Interviews were audiotaped, transcribed, and entered into a qualitative software program for coding and analysis. A multidisciplinary team of investigators coded the transcripts and identified key features of narratives expressing aversion to antidepressants. RESULTS: Four themes characterized resistance to antidepressants: (1) fear of dependence; (2) resistance to viewing depressive symptoms as a medical illness; (3) concern that antidepressants will prevent natural sadness; (4) prior negative experiences with medications for depression. CONCLUSIONS: Many elders resisted the use of antidepressants. Patients expressed concerns that seem to reflect their concept of depression as well as their specific concerns regarding antidepressants. These findings may enhance patient-provider communication about depression treatment in elders